|
US6500948B1
(en)
*
|
1995-12-08 |
2002-12-31 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
|
|
EA003294B1
(ru)
*
|
1995-12-08 |
2003-04-24 |
Агурон Фармасьютикалс, Инк. |
Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
|
|
US6747027B1
(en)
|
1996-07-22 |
2004-06-08 |
Pharmacia Corporation |
Thiol sulfonamide metalloprotease inhibitors
|
|
ATE233552T1
(de)
*
|
1996-07-22 |
2003-03-15 |
Monsanto Co |
Thiol-sulfonen als metalloproteinaseinhibitoren
|
|
BR9712792A
(pt)
*
|
1996-08-28 |
1999-12-14 |
Procter & Gamble |
Inibidores de metaloprotease bidentada.
|
|
HUP0000505A3
(en)
*
|
1996-08-28 |
2001-12-28 |
Procter & Gamble |
Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
|
|
US6872742B2
(en)
|
1996-08-28 |
2005-03-29 |
The Procter & Gamble Company |
Substituted cyclic amine metalloprotease inhibitors
|
|
BR9713465A
(pt)
*
|
1996-08-28 |
2000-03-28 |
Procter & Gamble |
Inibidores metalotprotease de amina cìclica sibstituìda
|
|
CN1228771A
(zh)
*
|
1996-08-28 |
1999-09-15 |
普罗克特和甘保尔公司 |
1,3－二杂环金属蛋白酶抑制剂
|
|
ATE226573T1
(de)
*
|
1996-08-28 |
2002-11-15 |
Procter & Gamble |
Heterozyklische metalloproteaseinhibitoren
|
|
US5929097A
(en)
*
|
1996-10-16 |
1999-07-27 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5962481A
(en)
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5977408A
(en)
*
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
KR20000049197A
(ko)
*
|
1996-10-16 |
2000-07-25 |
윌리암 에이취 캘넌, 에곤 이 버그 |
매트릭스 메탈로프로테이나제 및 종양 괴사 인자-α 전환 효소억제제로서의 오르토-설폰아미도 헤테로아릴 하이드록삼산의 제조 및 용도
|
|
US6228869B1
(en)
|
1996-10-16 |
2001-05-08 |
American Cyanamid Company |
Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US6008243A
(en)
*
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
US6174915B1
(en)
|
1997-03-25 |
2001-01-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
WO1998027069A1
(en)
*
|
1996-12-17 |
1998-06-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
US7115632B1
(en)
|
1999-05-12 |
2006-10-03 |
G. D. Searle & Co. |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
IL131493A
(en)
|
1997-03-04 |
2004-05-12 |
Monsanto Co |
Aromatic compounds of the hydroxamic sulfonyl alpha-deroxamic acid and their use in the preparation of drugs for the treatment of a condition associated with pathological activity of the metalloprotease matrix
|
|
US6696449B2
(en)
|
1997-03-04 |
2004-02-24 |
Pharmacia Corporation |
Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
|
|
US6794511B2
(en)
|
1997-03-04 |
2004-09-21 |
G. D. Searle |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
US6638952B1
(en)
|
1997-03-04 |
2003-10-28 |
Pharmacia Corporation |
Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
|
|
US6087359A
(en)
*
|
1997-03-04 |
2000-07-11 |
Getman; Daniel P. |
Thioaryl sulfonamide hydroxamic acid compounds
|
|
EP0983267B1
(en)
*
|
1997-03-04 |
2005-01-26 |
Pharmacia Corporation |
Amidoaromatic ring sulfonamide hydroxamic acid compounds
|
|
WO1998039316A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
N-hydroxy 4-sulfonyl butanamide compounds
|
|
US6362183B1
(en)
|
1997-03-04 |
2002-03-26 |
G. D. Searle & Company |
Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
|
|
US5985900A
(en)
*
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
EP0973748A1
(en)
*
|
1997-04-01 |
2000-01-26 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
AU7294098A
(en)
*
|
1997-05-09 |
1998-11-27 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
JP2004137284A
(ja)
*
|
1997-06-17 |
2004-05-13 |
Kaken Pharmaceut Co Ltd |
２−スルファモイル安息香酸誘導体
|
|
CN1265647A
(zh)
|
1997-07-31 |
2000-09-06 |
普罗克特和甘保尔公司 |
无环金属蛋白酶抑制剂
|
|
US6403632B1
(en)
*
|
2000-03-01 |
2002-06-11 |
Bristol Myers Squibb Pharma Co |
Lactam metalloprotease inhibitors
|
|
JPH11199512A
(ja)
*
|
1997-10-24 |
1999-07-27 |
Pfizer Prod Inc |
変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用
|
|
JP2001523662A
(ja)
|
1997-11-14 |
2001-11-27 |
ジー・ディー・サール・アンド・カンパニー |
芳香族スルホンヒドロキサム酸メタロプロテアーゼ阻害剤
|
|
US20010039287A1
(en)
|
1997-11-14 |
2001-11-08 |
Thomas E Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
US6750228B1
(en)
|
1997-11-14 |
2004-06-15 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
CN1293663A
(zh)
*
|
1998-01-27 |
2001-05-02 |
美国氰胺公司 |
为基质金属蛋白酶抑制剂的2,3,4,5－四氢－1h－[1,4]苯并二氮杂䓬－3－异羟肟酸
|
|
US6071903A
(en)
*
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
PL342009A1
(en)
|
1998-02-04 |
2001-05-07 |
Novartis Ag |
Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases
|
|
US6410580B1
(en)
|
1998-02-04 |
2002-06-25 |
Novartis Ag |
Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
|
|
US6329418B1
(en)
*
|
1998-04-14 |
2001-12-11 |
The Procter & Gamble Company |
Substituted pyrrolidine hydroxamate metalloprotease inhibitors
|
|
BR9910678A
(pt)
|
1998-05-14 |
2001-10-02 |
Du Pont Pharm Co |
Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto
|
|
WO1999065867A1
(en)
|
1998-06-17 |
1999-12-23 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
EP1357109B1
(en)
|
1998-06-18 |
2008-07-23 |
F. Hoffmann-La Roche Ag |
Process for aryl alkyl sulfide
|
|
FR2780402B1
(fr)
*
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
UA59453C2
(uk)
*
|
1998-08-12 |
2003-09-15 |
Пфайзер Продактс Інк. |
Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
|
|
WO2000009492A1
(en)
*
|
1998-08-12 |
2000-02-24 |
Pfizer Products Inc. |
Tace inhibitors
|
|
US6509337B1
(en)
*
|
1998-09-17 |
2003-01-21 |
Pfizer Inc. |
Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
US6300341B1
(en)
|
1998-09-30 |
2001-10-09 |
The Procter & Gamble Co. |
2-substituted heterocyclic sulfonamides
|
|
JP2002525305A
(ja)
*
|
1998-09-30 |
2002-08-13 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
スルホンアミドを用いた脱毛治療の方法
|
|
US6288261B1
(en)
*
|
1998-12-18 |
2001-09-11 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
US6858598B1
(en)
*
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
WO2000038715A2
(en)
*
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
Use of an integrin antagonist and radiation in the treatment of neoplasia
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
AR022423A1
(es)
*
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6544984B1
(en)
|
1999-01-27 |
2003-04-08 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
AU775701B2
(en)
|
1999-02-08 |
2004-08-12 |
G.D. Searle & Co. |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
US6800646B1
(en)
|
1999-02-08 |
2004-10-05 |
Pharmacia Corporation |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
SK12462001A3
(sk)
|
1999-03-03 |
2002-04-04 |
The Procter & Gamble Company |
Inhibítory metaloproteáz
|
|
KR20010102486A
(ko)
|
1999-03-03 |
2001-11-15 |
데이비드 엠 모이어 |
알케닐- 및 알키닐-함유 메탈로프로테아제 저해제
|
|
AUPP982399A0
(en)
*
|
1999-04-19 |
1999-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Mmp inhibitor
|
|
US6583299B1
(en)
|
1999-05-20 |
2003-06-24 |
G.D. Searle & Co. |
α-amino-β-sulfonyl hydroxamic acid compounds
|
|
US6869951B1
(en)
|
1999-07-16 |
2005-03-22 |
Pharmacia Corporation |
Method of changing conformation of a matrix metalloproteinase
|
|
PE20010659A1
(es)
|
1999-10-01 |
2001-06-20 |
Hoffmann La Roche |
Derivados de las pirimidin-2,4,6-trionas como inhibidores de metaloproteasas
|
|
IL151552A0
(en)
|
2000-03-17 |
2003-04-10 |
Bristol Myers Squibb Pharma Co |
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
|
|
ATE260272T1
(de)
*
|
2000-03-17 |
2004-03-15 |
Bristol Myers Squibb Pharma Co |
Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
|
|
EP1138680A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Pfizer Products Inc. |
Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
|
|
US6548667B2
(en)
*
|
2000-04-07 |
2003-04-15 |
Samsung Electronics Co. Ltd. |
Sulfonamide derivative as a matrix metalloproteinase inhibitor
|
|
US6683093B2
(en)
|
2000-05-12 |
2004-01-27 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors
|
|
US6927216B2
(en)
|
2000-10-03 |
2005-08-09 |
Bristol-Myers Squibb Pharma Company |
Cyclic sulfonyl compounds as inhibitors of metalloproteases
|
|
FR2819252A1
(fr)
*
|
2001-01-11 |
2002-07-12 |
Servier Lab |
Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6642255B2
(en)
|
2001-01-11 |
2003-11-04 |
Bristol-Myers Squibb Pharma Company |
1,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha
|
|
WO2002055516A2
(en)
|
2001-01-11 |
2002-07-18 |
Bristol Myers Squibb Co |
1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
|
|
MXPA01013326A
(es)
|
2001-02-14 |
2002-08-26 |
Warner Lambert Co |
Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
|
|
EP1373199A4
(en)
|
2001-03-15 |
2004-04-07 |
Bristol Myers Squibb Pharma Co |
SPIROCYCLIC BETA-AMINOACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND THE CONVERSION ENZYME OF TNF-ALPHA (TAGE)
|
|
US6716845B2
(en)
|
2001-03-30 |
2004-04-06 |
Hoffmann-La Roche Inc. |
Barbituric acid derivatives
|
|
JP2004530691A
(ja)
|
2001-05-11 |
2004-10-07 |
ファルマシア・コーポレーション |
芳香族スルホンヒドロキサメートおよびプロテアーゼ阻害剤としてのそれらの使用
|
|
WO2002096420A2
(en)
*
|
2001-05-29 |
2002-12-05 |
Guilford Pharmaceuticals Inc. |
Method for treating nerve injury caused by surgery
|
|
US6683078B2
(en)
|
2001-07-19 |
2004-01-27 |
Pharmacia Corporation |
Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
|
|
AUPR726201A0
(en)
*
|
2001-08-24 |
2001-09-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New use of a cyclic compound
|
|
JP2003081937A
(ja)
*
|
2001-09-07 |
2003-03-19 |
Bayer Ag |
ベンゼンスルホンアミド誘導体
|
|
JP2005507937A
(ja)
|
2001-11-01 |
2005-03-24 |
ワイス・ホールディングズ・コーポレイション |
マトリックスメタロプロテイナーゼおよびｔａｃｅ阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
|
|
WO2003048119A2
(en)
*
|
2001-11-30 |
2003-06-12 |
Bristol-Myers Squibb Company |
Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
CA2483314A1
(en)
|
2002-04-25 |
2003-11-06 |
Pharmacia Corporation |
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
AU2003233154A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Pfizer Inc. |
Metabolites of prinomastat and their sythesis
|
|
AU2003237532B2
(en)
*
|
2002-06-12 |
2009-07-30 |
Symphony Evolution, Inc. |
Human ADAM-10 inhibitors
|
|
US20040167182A1
(en)
*
|
2002-06-25 |
2004-08-26 |
Becker Daniel P. |
Hydroxamic acid and amide compounds and their use as protease inhibitors
|
|
US7199155B2
(en)
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
WO2004071390A2
(en)
*
|
2003-02-14 |
2004-08-26 |
Applied Research Systems Ars Holding N.V. |
Piperazine-2-carboxamide derivatives
|
|
JP2006517960A
(ja)
*
|
2003-02-18 |
2006-08-03 |
ファイザー インコーポレイテッド |
Ｃ型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
|
|
ZA200507806B
(en)
|
2003-03-24 |
2007-03-28 |
Actimis Pharmaceuticals Inc |
2-phenoxy- and 2-enysulfomamide derivatives with CCR3 antagonistic acitivity for the treatment of asthma and other inflammatory or immunolgical disorders
|
|
GT200500139A
(es)
|
2004-06-08 |
2005-07-25 |
|
Metodo para la preparacion de acidos hidroxamicos
|
|
DK2041181T3
(da)
*
|
2006-06-08 |
2011-08-29 |
Helmholtz Zentrum Muenchen |
Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
|
|
WO2009052200A2
(en)
*
|
2007-10-16 |
2009-04-23 |
Symphony Evolution, Inc. |
Human adam-10 inhibitors
|
|
EP2147684A1
(en)
*
|
2008-07-22 |
2010-01-27 |
Bracco Imaging S.p.A |
Diagnostic Agents Selective Against Metalloproteases
|
|
WO2011081884A1
(en)
|
2009-12-14 |
2011-07-07 |
Massachusetts Institute Of Technology |
Systems and methods related to optical nanosensors including photoluminescent nanostructures
|
|
IT1401253B1
(it)
|
2010-04-23 |
2013-07-18 |
Uni Degli Studi Carlo Bo Urbino |
Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.
|
|
CN103998435A
(zh)
*
|
2011-10-04 |
2014-08-20 |
法国国家健康医疗研究院 |
新型细胞凋亡诱导化合物
|
|
EP3860608A1
(en)
|
2018-10-04 |
2021-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Egfr inhibitors for treating keratodermas
|
|
KR102890026B1
(ko)
*
|
2019-04-26 |
2025-11-24 |
닛산 가가쿠 가부시키가이샤 |
아릴술폰산 에스테르 화합물의 제조 방법
|
|
WO2020252439A1
(en)
*
|
2019-06-14 |
2020-12-17 |
Loyola University Of Chicago |
Carborane hydroxamic acid matrix metalloproteinase agents for boron neutron capture therapy
|